(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566909

静脈内水分補給療法市場：サービス別、コンポーネント別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Intravenous Hydration Therapy Market By Service, By Component By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 220 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
静脈内水分補給療法市場：サービス別、コンポーネント別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 220 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

静脈内（IV）水分補給療法市場

静脈内（IV）水分補給療法市場は、2023年に23億米ドルと評価され、2024年から2033年にかけてCAGR 7.8%で成長し、2033年には49億米ドルに達すると予測されています。

静脈内（IV）水分補給療法は、薬物、水分、ビタミン、電解質を静脈を通して血流に直接注入する医療処置です。この療法は、脱水によって失われた必須水分と栄養素を効率的かつ迅速に補給することができるため、非常に効果的な処置です。脱水とは、何らかの病気や過度の飲酒、激しい運動などによって体内の水分が過剰に失われることです。この治療は、慢性疾患の管理、術前・術後のケア、重度の感染症や胃腸障害を持つ患者の治療など、さまざまな医療現場で応用されています。

静脈内（IV）水分補給療法市場の主な促進要因の1つは、ストレスレベルの高い人々の間で気張ったライフスタイルが増加していることです。ストレスの多いライフスタイルは、個人の脱水症状を増加させる最も一般的な理由の1つです。さらに、病気や入院の影響を受けやすい老年人口が世界中で急増しています。これが静脈内水分補給療法の需要を押し上げ、市場の成長を増大させています。最近では、セルフケアや若返りの一環として静脈内水分補給療法を行うことが、特にセレブの間で流行しています。さらに、リラクゼーションの一環として治療を受けるための「水分補給バー」と呼ばれる専門センターも設立されています。

しかし、経口補水液のような他の水分補給療法が利用可能であることが、市場の開拓を抑制しています。さらに、特に地方では、専用の医療施設や十分な訓練を受けたスタッフが不足しており、市場拡大の課題となっています。逆に、技術の進歩や治療中に投与される従来の製剤の改良は、市場成長にとって有利な機会をもたらしています。例えば、一人ひとりの要望に応じて個別化されたソリューションが開発され、健康目標の達成に役立っています。

セグメント別レビュー

静脈内水分補給療法市場は、サービス、コンポーネント、エンドユーザー、地域に区分されます。サービス別では、市場は免疫ブースター、エネルギーブースター、スキンケア、片頭痛、その他に分けられます。成分別では、薬用と非薬用に二分されます。エンドユーザー別では、病院＆クリニック、ウェルネスセンター＆スパ、ホームヘルスケア、その他に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されます。

主な調査結果

サービス別では、免疫増強剤が市場を独占しています。

成分別では、薬用セグメントが市場で大きな需要を獲得しています。

エンドユーザー別では、病院・診療所が高いシェアを獲得しています。

地域別では、北米が市場をリードしています。

本レポートのカスタマイズが可能です（別途費用とスケジュールが必要です。）

  • 規制ガイドライン
  • クライアントの関心に応じた企業プロファイルの追加
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 償還シナリオ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 静脈内水分補給療法市場：サービス別

  • 市場概要
  • 免疫ブースター
  • エネルギー・ブースター
  • スキンケア
  • 偏頭痛
  • その他

第5章 静脈内水分補給療法市場：コンポーネント別

  • 市場概要
  • 薬用
  • 非薬用

第6章 静脈内水分補給療法市場：エンドユーザー別

  • 市場概要
  • 病院クリニック
  • ウェルネスセンター・スパ
  • 在宅ヘルスケア
  • その他

第7章 静脈内水分補給療法市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の静脈内（IV）水分補給療法市場
    • カナダの静脈内水分補給療法市場
    • メキシコの静脈内水分補給療法市場
  • 欧州
    • 主な市場動向と機会
    • フランスの静脈内水分補給療法市場
    • ドイツの静脈内水分補給療法市場
    • イタリアの静脈内水分補給療法市場
    • スペインの静脈内水分補給療法市場
    • 英国の静脈内水分補給療法市場
    • その他欧州の静脈内水分補給療法市場
  • アジア太平洋
    • 主な市場動向と機会
    • 中国の静脈内水分補給療法市場
    • 日本の静脈内水分補給療法市場
    • インド静脈内水分補給療法市場
    • 韓国の静脈内水分補給療法市場
    • オーストラリア静脈内水分補給療法市場
    • その他アジア太平洋の静脈内水分補給療法市場
  • ラテンアメリカ・中東・アフリカ
    • 主な市場動向と機会
    • ブラジルの静脈内水分補給療法市場
    • 南アフリカ共和国の静脈内水分補給療法市場
    • サウジアラビアの静脈内水分補給療法市場
    • その他のラテンアメリカ・中東・アフリカの静脈内水分補給療法市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第9章 企業プロファイル

  • Davita
  • Nikkiso Co. Ltd.
  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health
  • JW Life Science Corporation
  • Amanta Healthcare Limited.
  • Baxter International Inc.
目次
Product Code: A323708

Intravenous (IV) Hydration Therapy Market

The intravenous (IV) hydration therapy market was valued at $2.3 billion in 2023 and is projected to reach $4.9 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.

Intravenous (IV) hydration therapy is the medical procedure in which medications, fluids, vitamins, and electrolytes are infused directly into the bloodstream through a vein. The therapy is a highly effective procedure as it ensures efficient and quick replenishment of essential fluids and nutrients lost due to dehydration. Dehydration is the excessive loss of fluids from the body caused by some illness, excessive alcohol consumption, or intense physical activity. The treatment is applicable in diverse medical settings for the management of chronic conditions, preoperative & postoperative care, and to cure patients with severe infections or gastrointestinal problems.

One of the key drivers of the intravenous (IV) hydration therapy market is increase in uptight lifestyle among individuals with high stress levels. A stressed lifestyle is one of the most common reasons for rising dehydration among individuals. In addition, the geriatric population is growing exponentially across the globe, who are highly susceptible to ailments and hospitalization. This boosts the demand for IV hydration therapy, thus augmenting the market growth. In recent times, the administration of IV therapy as a part of self-care routine or rejuvenation is trending, particularly among celebrities. Moreover, specialized centers called "hydration bars" are being established for people to receive therapy as a form of relaxation.

However, the availability of other alternatives for hydration therapy, such as the oral rehydration solutions restrain the development of the market. Furthermore, the shortage of dedicated medical facilities and well-trained staff, particularly in rural areas, presents challenges for the expansion of the market. On the contrary, advancements in technology and modifications in the conventional formulations administered during treatment are presenting lucrative opportunities for market growth. For instance, personalized solutions are being developed according to the requirements of every individual, hence aiding them to achieve their health goal.

Segment Review

The intravenous (IV) hydration therapy market is segmented into service, component, end user, and region. On the basis of service, the market is divided into immune boosters, energy boosters, skin care, migraine, and others. By component, it is bifurcated into medicated and non-medicated. As per end user, it is categorized into hospital & clinics, wellness centers & spas, home healthcare, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of service, the immune boosters segment dominates the market.

By component, the medicated segmented experiences significant demand in the market.

As per end user, the hospital & clinics segment acquires a high share of the market.

Region wise, North America leads the market.

Competition Analysis

The major players operating in the global intravenous (IV) hydration therapy market include Davita, Nikkiso Co. Ltd., Core IV Therapy, LLC, Cryojuvenate UK Ltd., B. Braun Medical Inc., Otsuka Pharmaceutical Co., Ltd., NexGen Health, JW Life Science Corporation, Amanta Healthcare Limited., and Baxter International Inc. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Service

  • Immune boosters
  • Energy boosters
  • Skin care
  • Migraine
  • Others

By Component

  • Medicated
  • Non-medicated

By End User

  • Hospital clinics
  • Wellness centers spas
  • Home healthcare
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Davita
    • Nikkiso Co. Ltd.
    • Core IV Therapy, LLC
    • Cryojuvenate UK Ltd.
    • B. Braun Medical Inc.
    • Otsuka Pharmaceutical Co., Ltd.
    • NexGen Health
    • JW Life Science Corporation
    • Amanta Healthcare Limited.
    • Baxter International Inc.?

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY SERVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Service
  • 4.2. Immune Boosters
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Energy Boosters
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Skin Care
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Migraine
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Others
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY COMPONENT

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Component
  • 5.2. Medicated
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Non-medicated
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospital Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Wellness Centers Spas
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Home Healthcare
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Others
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: INTRAVENOUS (IV) HYDRATION THERAPY MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Service
    • 7.2.3. Market Size and Forecast, By Component
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Intravenous (IV) Hydration Therapy Market
      • 7.2.6.1. Market Size and Forecast, By Service
      • 7.2.6.2. Market Size and Forecast, By Component
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Intravenous (IV) Hydration Therapy Market
      • 7.2.7.1. Market Size and Forecast, By Service
      • 7.2.7.2. Market Size and Forecast, By Component
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Intravenous (IV) Hydration Therapy Market
      • 7.2.8.1. Market Size and Forecast, By Service
      • 7.2.8.2. Market Size and Forecast, By Component
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Service
    • 7.3.3. Market Size and Forecast, By Component
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Intravenous (IV) Hydration Therapy Market
      • 7.3.6.1. Market Size and Forecast, By Service
      • 7.3.6.2. Market Size and Forecast, By Component
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Intravenous (IV) Hydration Therapy Market
      • 7.3.7.1. Market Size and Forecast, By Service
      • 7.3.7.2. Market Size and Forecast, By Component
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Intravenous (IV) Hydration Therapy Market
      • 7.3.8.1. Market Size and Forecast, By Service
      • 7.3.8.2. Market Size and Forecast, By Component
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Intravenous (IV) Hydration Therapy Market
      • 7.3.9.1. Market Size and Forecast, By Service
      • 7.3.9.2. Market Size and Forecast, By Component
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Intravenous (IV) Hydration Therapy Market
      • 7.3.10.1. Market Size and Forecast, By Service
      • 7.3.10.2. Market Size and Forecast, By Component
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Intravenous (IV) Hydration Therapy Market
      • 7.3.11.1. Market Size and Forecast, By Service
      • 7.3.11.2. Market Size and Forecast, By Component
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Service
    • 7.4.3. Market Size and Forecast, By Component
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Intravenous (IV) Hydration Therapy Market
      • 7.4.6.1. Market Size and Forecast, By Service
      • 7.4.6.2. Market Size and Forecast, By Component
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Intravenous (IV) Hydration Therapy Market
      • 7.4.7.1. Market Size and Forecast, By Service
      • 7.4.7.2. Market Size and Forecast, By Component
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Intravenous (IV) Hydration Therapy Market
      • 7.4.8.1. Market Size and Forecast, By Service
      • 7.4.8.2. Market Size and Forecast, By Component
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Intravenous (IV) Hydration Therapy Market
      • 7.4.9.1. Market Size and Forecast, By Service
      • 7.4.9.2. Market Size and Forecast, By Component
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Intravenous (IV) Hydration Therapy Market
      • 7.4.10.1. Market Size and Forecast, By Service
      • 7.4.10.2. Market Size and Forecast, By Component
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Intravenous (IV) Hydration Therapy Market
      • 7.4.11.1. Market Size and Forecast, By Service
      • 7.4.11.2. Market Size and Forecast, By Component
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Service
    • 7.5.3. Market Size and Forecast, By Component
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Intravenous (IV) Hydration Therapy Market
      • 7.5.6.1. Market Size and Forecast, By Service
      • 7.5.6.2. Market Size and Forecast, By Component
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Intravenous (IV) Hydration Therapy Market
      • 7.5.7.1. Market Size and Forecast, By Service
      • 7.5.7.2. Market Size and Forecast, By Component
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Intravenous (IV) Hydration Therapy Market
      • 7.5.8.1. Market Size and Forecast, By Service
      • 7.5.8.2. Market Size and Forecast, By Component
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Intravenous (IV) Hydration Therapy Market
      • 7.5.9.1. Market Size and Forecast, By Service
      • 7.5.9.2. Market Size and Forecast, By Component
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Davita
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Nikkiso Co. Ltd.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Core IV Therapy, LLC
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Cryojuvenate UK Ltd.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. B. Braun Medical Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Otsuka Pharmaceutical Co., Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. NexGen Health
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. JW Life Science Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Amanta Healthcare Limited.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Baxter International Inc.?
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments